Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.
- 浏览0
The journal of pain
175-184页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



